Following treatment with IL-1, an increase in MMP-3 gene expression was seen in the four cell types investigated (though the increase was significant only in cells derived from the non-degenerate NP and AF (P < 0.05)) (Fig. 4a). This evidence concerns the gene IL1A and atrial fibrillation.